INDIA MARKET LENS
Companies▼ NegativeQuarterly Results

Groww Q2 Results: CAS Pain Hits Sequential Growth, But Brokerage Eyes Relief From SEBI Proposal

Groww is in focus in a quarterly results development.

· NDTV Profit

In its shareholder letter, management said the fall in Groww's equity derivatives revenue was in line with the broader industry trend.

Against that, the stock is +0.2% on the day at ₹191.52, and has returned -0.4% over three months. It sits 14% below its 52-week high. The capital markets sector has moved -6.3% over the same period, so Groww is running 5.9 points ahead of its peers.

For Groww, the question is how much of this is already reflected in the price and how much re-rates the capital markets peer set alongside it.

  • Earnings versus expectations is what actually re-rates a stock; the surprise matters more than the absolute number.
  • With SEBI involved, this carries a regulatory dimension that can outlast the immediate market reaction.
  • In focus: Groww (GROWW), in Capital Markets.
  • Over three months: Groww -0.4% against Capital Markets -6.3% (5.9 points ahead).
Figures for the companies in this story
CompanyPriceDay1M3MFrom 52-wk highVolume vs 20-dayMarket cap
GrowwGROWW · Capital Markets₹191.52+0.2%+4.1%-0.4%-13.6%0.6×—

Capital Markets

1M -2.9% · 3M -6.3%

Groww

Prices as of 30 Oct 2026, 16:10 IST. Sector moves are the average of the stocks we track in each sector.

GROWWCapital Markets